ÂÜÀòÂÒÂ×

Mark Connolly is currently the Executive Director of Corporate Development at Tessera Therapeutics. Prior to that, Mark held positions as Senior Director of Corporate Development and Director of Strategy within the company. With a background in finance and accounting, Mark has previous experience at Credit Suisse as Vice President in Small and Mid-Cap Biotechnology Equity Research, UBS as an Equity Research Associate, and RSM US LLP as a Supervisor. Additionally, Mark worked at the Financial Accounting Standards Board as an XBRL Research Assistant and at PwC as an Audit Intern. Mark graduated from the University of Connecticut with a Bachelor's Degree in Accounting, Economics, and Environmental Economics.